ATEX vs EVER
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
The Advanced Deterministic Scorecard reveals a weak financial health profile with a Piotroski F-Score of just 2/9, signaling significant operational and profitability concerns. Despite a low P/E of 4.72 and a Graham Number of $38.17 suggesting undervaluation, the negative forward P/E, erratic earnings, and extremely high reported profit margin of 1614% indicate unreliable profitability metrics. The stock trades well below analyst target of $55.33, but weak revenue growth, negative operating margins, and bearish insider activity raise sustainability concerns. Technical trend at 0/100 and declining long-term price performance further support a cautious outlook.
EVER shows bullish fundamentals based on deterministic rules. Financial strength is weak (F-Score 3/9). Key strengths include strong valuation and growth metrics.
Compare Another Pair
Related Comparisons
ATEX vs EVER: Head-to-Head Comparison
This page compares Anterix Inc. (ATEX) and EverQuote, Inc. (EVER) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.